/4512.T
4512.T Stock - Wakamoto Pharmaceutical Co.,Ltd.
Healthcare|Drug Manufacturers - Specialty & GenericJPX
$289.00+1.76%
+$5.00 (+1.76%) • Dec 24
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.49
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.98
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $317.90
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4512.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$286.11 – $291.89
TARGET (TP)$332.35
STOP LOSS$265.88
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.56
52W High$377.00
52W Low$209.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7.79B | $7.74B | $8.66B | $8.38B | $8.89B |
| Gross Profit | $3.62B | $3.54B | $4.11B | $4.36B | $4.49B |
| Gross Margin | 46.5% | 45.8% | 47.4% | 52.0% | 50.5% |
| Operating Income | $-457,796,000 | $-195,511,000 | $141.47M | $-13,386,000 | $-754,947,000 |
| Net Income | $64.44M | $108.96M | $138.26M | $238.54M | $-601,856,000 |
| Net Margin | 0.8% | 1.4% | 1.6% | 2.8% | -6.8% |
| EPS | $1.86 | $3.14 | $3.98 | $6.87 | $-17.34 |
Company Overview
Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. The company offers Strong Wakamoto, a gastrointestinal drug for digestion, intestinal regulation, and nutritional supplementation. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4512.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.74
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q1 2026 | Feb 3, 2026 | — | — | — | — |
Q4 2025 | Nov 6, 2025 | — | $-0.74 | — | — |
Q3 2025 | Aug 5, 2025 | — | $-3.12 | — | — |
Q2 2025 | May 15, 2025 | — | $2.41 | — | — |
Q1 2025 | Feb 3, 2025 | — | $3.53 | — | — |
Q4 2024 | Nov 6, 2024 | — | $-3.75 | — | — |
Q3 2024 | Aug 2, 2024 | — | $-0.33 | — | — |
Q2 2024 | May 15, 2024 | — | $0.80 | — | — |
Q1 2024 | Feb 5, 2024 | — | $0.50 | — | — |
Q4 2023 | Nov 6, 2023 | — | $-9.32 | — | — |
Q3 2023 | Aug 4, 2023 | — | $2.90 | — | — |
Q2 2023 | May 15, 2023 | — | $0.80 | — | — |
Q1 2023 | Feb 2, 2023 | — | $3.80 | — | — |
Q4 2022 | Nov 7, 2022 | — | $-0.48 | — | — |
Q3 2022 | Aug 4, 2022 | — | $-0.14 | — | — |
Q2 2022 | May 16, 2022 | — | $0.81 | — | — |
Q1 2022 | Feb 2, 2022 | — | $2.84 | — | — |
Q4 2021 | Nov 4, 2021 | — | $1.94 | — | — |
Q3 2021 | Aug 4, 2021 | — | $1.29 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4512.T
What is 4512.T's current stock price?
Wakamoto Pharmaceutical Co.,Ltd. (4512.T) is currently trading at $289.00 per share. The stock has moved +1.76% today.
What is the analyst price target for 4512.T?
No analyst price targets are currently available for this stock.
What sector is Wakamoto Pharmaceutical Co.,Ltd. in?
Wakamoto Pharmaceutical Co.,Ltd. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the JPX exchange.
What is 4512.T's market cap?
Wakamoto Pharmaceutical Co.,Ltd. has a market capitalization of $10.03 billion, making it a large-cap company.
Does 4512.T pay dividends?
No, Wakamoto Pharmaceutical Co.,Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector160A.T
AS Partners Co. Ltd.
$2541.00
Mkt Cap: $9.1B
194A.T
WOLVES HAND Co., Ltd.
$1805.00
Mkt Cap: $13.5B
2934.T
J Frontier Co.,Ltd.
$1284.00
Mkt Cap: $6.7B
3446.T
JTEC Corporation
$1189.00
Mkt Cap: $7.0B
3671.T
Softmax Co., Ltd
$373.00
Mkt Cap: $9.0B
4524.T
Morishita Jintan Co., Ltd.
$2153.00
Mkt Cap: $8.8B
4597.T
Solasia Pharma K.K.
$28.00
Mkt Cap: $7.2B
4880.T
CellSource Co., Ltd.
$392.00
Mkt Cap: $7.8B
7702.T
JMS Co.,Ltd.
$441.00
Mkt Cap: $10.8B
9341.T
GENOVA, Inc.
$564.00
Mkt Cap: $9.8B
Explore stocks similar to 4512.T for comparison